Nature Briefing
"Gene-activity 'clock' predicts biological ageing and time of death."
Views expressed in this science and technology update are those of the reporters and correspondents. Accessed on 28 May 2026, 2150 UTC.
Content and Source: "Nature Briefing."
https://mail.google.com/mail/u/0/#inbox/FMfcgzQgMCZXTMsFPzZPSCFgXlDXQSvW
URL--https://www.nature.com.
Please check email link, URL, or scroll down to read your selections. Thanks for joining us today.
Russ Roberts (https://hawaiisciencemonitor.blogspot.com).
| |||||
| |||||
Hello Nature readers, | |||||
![]() | |||||
| Zebrafish’s bodies are transparent for their first few weeks of life, which gave researchers a window into the fish’s brains while they slept. (WireStock via Alamy) | |||||
Zebrafish snooze in four distinct stagesZebrafish (Danio spp.) sleep in different stages that resemble the ‘cycles’ of sleep described in people. By tracking the eye movements of snoozing fish, researchers identified four ‘substates’ of sleep — three associated with nighttime slumber and one with short naps during the day. Identifying these distinct sleep states could help researchers to untangle what purpose they serve in fish and other animals. “It’s like a lot of things in biology: The more we look under the hood, the more complex it is,” says marine ecologist Michael Heithaus. The New York Times | 3 min readReference: Nature Communications paper | |||||
Gene-activity clock predicts time to deathA powerful molecular clock calibrated using gene-activity data can predict biological ageing in rodents, monkeys and humans — and time to death in people. Although it isn’t ready for medical use, the tool could eventually be a boon to biologists keen to learn which drugs or lifestyle changes might mitigate ageing’s myriad effects on the body. A gene-activity clock could be more sensitive than those based on molecular changes to DNA, which are slower to respond and might not capture the impacts of environmental changes, says computational biologist and study co-author Alexander Tyshkovskiy. Nature | 5 min readReference: Nature paper | |||||
NSF quietly limits funding for elite unisThe US National Science Foundation (NSF) — a major funder of basic research — has restricted the flow of new research grants to four elite universities. According to internal agency documents seen by Nature, the NSF’s grants-management office put limits on new awards to Duke, Harvard, Yale and Princeton at the beginning of April, and little funding has been made available to these institutions since then. It’s not clear why the NSF has put these restrictions in place, or when it will lift them. Nature | 6 min read | |||||
Spinosauruses might’ve ‘cried’ salty tearsSome spinosauruses (Spinosauridae) might have had a specialized gland that enabled them to purge salt from their bodies. Researchers noticed grooves in the fossilized skulls of spinosaurs such as Baryonyx walkeri and Irritator challengeri in around the same place that the salt gland rests in modern bird species such as seagulls (Larinae). The findings suggest that these dinos might’ve had a similar organ, and lend support to the theory that spinosauruses were at least semi-aquatic. “If they’re in the water a long time, they need a salt gland,” says palaeontologist David Martill. Science | 5 min readReference: Historical Biology paper | |||||
| |||||
Leave reviews to human expertsArtificial intelligence models shouldn’t be trusted to conduct systematic reviews of scientific literature on their own, argues Rupa Sarkar, editor-in-chief of the Cochrane Collaboration, which produces gold-standard reviews of medical literature. Conducting systematic reviews isn’t a purely computational task and requires nuanced human expertise that models don’t often possess. AI tools can lighten some of the load of conducting a review, such as compiling structured data sets from disparate sources, but they should be used to support, not replace, scientists, Sarkar writes. Nature | 5 min read | |||||
Video: a pill that ‘intercepts’ lung cancerMutations might lay the foundations for lung cancer, but evidence suggests that inflammation is what sparks the first stages of tumour development. “Stopping mutation is something very difficult. However, we know how to stop inflammation,” says physician-scientist Miriam Merad. Researchers are now investigating the use of anti-inflammatory drugs to nip lung cancer in the bud — a burgeoning field known as cancer ‘interception’. Nature | 19 min videoThis article is part of Nature Outlook: Lung cancer, an editorially-independent supplement produced with financial support from Daiichi Sankyo and MSD. | |||||
| |||||
![]() | |||||
| Using a technique called spatial transcriptomics, researchers have compiled an atlas of gene expression in 4- to 8-week-old human embryos that captures the early growth of 50 different organs, each indicated here in a different colour. The atlas could be used to identify how genetic variants affect development in people with congenital conditions, or help to explain why fetuses are susceptible to infections with, for example, Zika virus. (Nature News & Views | 4 min read) Reference: Nature paper | |||||
| |||||
| |||||
You received this newsletter because you subscribed with the email address: kh6jrm@gmail.com Please add briefing@nature.com to your address book. Enjoying this newsletter? You can use this form to recommend it to a friend or colleague — thank you! Had enough? To unsubscribe from this Briefing, but keep receiving your other Nature Briefing newsletters, please update your subscription preferences. To stop all Nature Briefing emails forever, click here to remove your personal data from our system. Fancy a bit of a read? View our privacy policy. Forwarded by a friend? Get the Briefing straight to your inbox: subscribe for free. Want to master time management, protect your mental health and brush up on your skills? Sign up for our free short e-mail series for working scientists, Back to the lab. Get more from Nature: Register for free on nature.com to sign up for other newsletters specific to your field and email alerts from Nature Portfolio journals. Would you like to read the Briefing in other languages? 关注Nature Portfolio官方微信订阅号,每周二为您推送Nature Briefing精选中文内容——自然每周简报。 Nature Portfolio | The Springer Nature Campus, 4 Crinan Street, London, N1 9XW, United Kingdom Nature Portfolio, part of Springer Nature. |




Comments
Post a Comment